NO871352D0 - Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer. - Google Patents
Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer.Info
- Publication number
- NO871352D0 NO871352D0 NO871352A NO871352A NO871352D0 NO 871352 D0 NO871352 D0 NO 871352D0 NO 871352 A NO871352 A NO 871352A NO 871352 A NO871352 A NO 871352A NO 871352 D0 NO871352 D0 NO 871352D0
- Authority
- NO
- Norway
- Prior art keywords
- human tumor
- procedures
- mixtures
- identification
- disclosed
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000001394 metastastic effect Effects 0.000 title abstract 2
- 206010061289 metastatic neoplasm Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 210000004881 tumor cell Anatomy 0.000 abstract 3
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Stereophonic System (AREA)
- Radar Systems Or Details Thereof (AREA)
- Communication Control (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Air Conditioning Control Device (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/846,938 US5030559A (en) | 1986-04-01 | 1986-04-01 | Methods and compositions for the identification of metastatic human tumors |
Publications (4)
Publication Number | Publication Date |
---|---|
NO871352D0 true NO871352D0 (no) | 1987-03-31 |
NO871352L NO871352L (no) | 1987-10-02 |
NO175642B NO175642B (no) | 1994-08-01 |
NO175642C NO175642C (no) | 1994-11-09 |
Family
ID=25299361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO871352A NO175642C (no) | 1986-04-01 | 1987-03-31 | Hovedsakelig rent humant tumor gp580 antigen, fremgangsmåte for fremstilling derav, antistoff mot dette, kontinuerlig hybrid cellelinje som produserer antistoffet og anvendelse av antistoffet ved in vitro diagnose |
Country Status (11)
Country | Link |
---|---|
US (1) | US5030559A (no) |
EP (1) | EP0240341B1 (no) |
JP (1) | JPH0742320B2 (no) |
AT (1) | ATE105569T1 (no) |
AU (1) | AU599364B2 (no) |
CA (1) | CA1307478C (no) |
DE (1) | DE3789781T2 (no) |
DK (1) | DK162387A (no) |
ES (1) | ES2051737T3 (no) |
FI (1) | FI89806C (no) |
NO (1) | NO175642C (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE403802B (sv) * | 1972-10-10 | 1978-09-04 | Buchegger Masch Reinigung | Anordning for rengoring och avfettning av maskindelar och liknande |
US5646004A (en) * | 1994-08-31 | 1997-07-08 | Activated Cell Therapy, Inc. | Methods for enriching fetal cells from maternal body fluids |
US5840502A (en) * | 1994-08-31 | 1998-11-24 | Activated Cell Therapy, Inc. | Methods for enriching specific cell-types by density gradient centrifugation |
US5648223A (en) * | 1994-08-31 | 1997-07-15 | Activated Cell Therapy, Inc. | Methods for enriching breast tumor cells |
US5663051A (en) * | 1994-08-31 | 1997-09-02 | Activated Cell Therapy, Inc. | Separation apparatus and method |
DE19530272C1 (de) * | 1995-08-17 | 1996-11-21 | Univ Eberhard Karls | Antikörper 103 B2 |
DE19530273C1 (de) * | 1995-08-17 | 1996-12-12 | Univ Eberhard Karls | Antikörper 105A5 |
CA2429723A1 (en) * | 2000-11-28 | 2002-06-06 | Wyeth | Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
AU2002236503C1 (en) * | 2000-11-28 | 2008-11-13 | Wyeth | Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
CA2429722A1 (en) * | 2000-11-28 | 2002-06-06 | Wyeth | Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
US7169722B2 (en) * | 2002-01-28 | 2007-01-30 | Guardian Industries Corp. | Clear glass composition with high visible transmittance |
US7482116B2 (en) | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
CL2007002615A1 (es) * | 2006-09-08 | 2008-04-18 | Wyeth Corp | Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto. |
US10745701B2 (en) | 2007-06-28 | 2020-08-18 | The Trustees Of Princeton University | Methods of identifying and treating poor-prognosis cancers |
US20090324596A1 (en) * | 2008-06-30 | 2009-12-31 | The Trustees Of Princeton University | Methods of identifying and treating poor-prognosis cancers |
CA2839693A1 (en) * | 2011-06-19 | 2012-12-27 | Abogen, Inc. | Devices, solutions and methods for sample collection |
CN107430105A (zh) | 2015-02-09 | 2017-12-01 | 阿波根有限公司 | 用于采集相关应用、分析和诊断的样本的设备、溶液和方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3697638A (en) * | 1970-06-01 | 1972-10-10 | Hoffmann La Roche | Antigens |
US4145336A (en) * | 1976-04-30 | 1979-03-20 | Scripps Clinic And Research Foundation | Carcinoembryonic antigen isomer |
US4140753A (en) * | 1976-04-30 | 1979-02-20 | Scripps Clinic & Research Foundation | Diagnostic method and reagent |
IN150740B (no) * | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
US4444744A (en) * | 1980-03-03 | 1984-04-24 | Goldenberg Milton David | Tumor localization and therapy with labeled antibodies to cell surface antigens |
DE3586216T2 (de) * | 1984-05-01 | 1992-12-10 | Ciba Corning Diagnostics Corp | Brusttumorassoziiertes antigen und monoklonale antikoerper dazu. |
-
1986
- 1986-04-01 US US06/846,938 patent/US5030559A/en not_active Expired - Fee Related
-
1987
- 1987-03-30 CA CA000533286A patent/CA1307478C/en not_active Expired - Lifetime
- 1987-03-30 AU AU70753/87A patent/AU599364B2/en not_active Ceased
- 1987-03-31 FI FI871411A patent/FI89806C/fi not_active IP Right Cessation
- 1987-03-31 DK DK162387A patent/DK162387A/da not_active Application Discontinuation
- 1987-03-31 NO NO871352A patent/NO175642C/no unknown
- 1987-04-01 ES ES87302848T patent/ES2051737T3/es not_active Expired - Lifetime
- 1987-04-01 DE DE3789781T patent/DE3789781T2/de not_active Expired - Fee Related
- 1987-04-01 AT AT8787302848T patent/ATE105569T1/de not_active IP Right Cessation
- 1987-04-01 EP EP87302848A patent/EP0240341B1/en not_active Expired - Lifetime
- 1987-04-01 JP JP62080856A patent/JPH0742320B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3789781D1 (de) | 1994-06-16 |
FI89806B (fi) | 1993-08-13 |
NO175642C (no) | 1994-11-09 |
EP0240341A2 (en) | 1987-10-07 |
DE3789781T2 (de) | 1994-11-10 |
AU7075387A (en) | 1987-10-08 |
NO871352L (no) | 1987-10-02 |
US5030559A (en) | 1991-07-09 |
FI871411A (fi) | 1987-10-02 |
FI871411A0 (fi) | 1987-03-31 |
AU599364B2 (en) | 1990-07-19 |
JPS62253395A (ja) | 1987-11-05 |
JPH0742320B2 (ja) | 1995-05-10 |
DK162387D0 (da) | 1987-03-31 |
FI89806C (fi) | 1993-11-25 |
EP0240341A3 (en) | 1989-07-19 |
ATE105569T1 (de) | 1994-05-15 |
ES2051737T3 (es) | 1994-07-01 |
DK162387A (da) | 1987-10-02 |
NO175642B (no) | 1994-08-01 |
CA1307478C (en) | 1992-09-15 |
EP0240341B1 (en) | 1994-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO871352D0 (no) | Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer. | |
EP0288082A3 (en) | A tumor specific assay for ca125 ovarian cancer antigen | |
WO1999004265A8 (en) | Cancer associated nucleic acids and polypeptides | |
FI854604A0 (fi) | Onkostatiini-A:n käyttö diagnostisessa menetelmässä | |
WO2000036107A3 (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
EP1630235A3 (en) | Compounds for immunodiagnosis of prostate cancer and method for their use | |
EP0102381A4 (en) | METHOD FOR IDENTIFYING AND CLEANING ANTIGENS (hLTAA) ASSOCIATED WITH HUMAN LUNG TUMOR AND CLINICALLY DETECTING AND DETERMINING THIS ANTIGENS. | |
OA08485A (fr) | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas. | |
NO885013D0 (no) | Fremgangsmte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppndd ved fremgangsmten. | |
EP0163303A3 (en) | Human monoclonal antibodies to cell surface and intracellular antigens | |
GB2182949A (en) | Monoclonal antibodies and antigens for human non-small cell lung carcinomas | |
JPS5386016A (en) | Identification * diagnostic and immunological method for surface protein of cancer cell | |
CA2207505A1 (en) | Neurological drug screens | |
NO960925D0 (no) | Diagnostiske, prognostiske og terapeutiske metoder for faste, ikke-lymfoide tumorer og deres metastaser | |
SE8100011L (sv) | Detektering av cancerceller | |
DK0454782T3 (da) | Cancer-beslægtet haptaglobin (Hpr.) | |
CA2294514A1 (en) | Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum | |
AU2883597A (en) | Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy | |
ES8707863A1 (es) | Un procedimiento para producir un anticuerpo monoclonal para carcinoma de pulmon humano de celulas no pequenas. | |
WO1991017187A3 (en) | A 35kd tumor associated protein antigen: uses and methods of detection | |
DE3582191D1 (de) | Verwendung eines spezifischen karzinomassoziierenden antigens (hapten), fucosylsialosylgangliotetrose (fuc-gm1) in diagnostischen und therapeutischen verfahren betreffend den menschlichen lungenkrebs (carcinomas von kleinen zellen). | |
ØRJASæTER | STUDY OF SUBSTANCES RELATED TO CARCINOEMBRYONIC ANTIGENS, CEA‐NCA AND ASSOCIATION WITH α1‐ANTICHYMOTRYPSIN | |
NZ333075A (en) | isolated protein markers for use in diagnosing esophageal cancer | |
AU5752490A (en) | A novel tumor associated antigen | |
EP0272113A3 (en) | Anti-human cancer monoclonal antibodies |